<DOC>
	<DOCNO>NCT01872611</DOCNO>
	<brief_summary>The purpose study demonstrate superiority Nepafenac Ophthalmic Suspension , 0.3 % dosed daily relative Nepafenac Vehicle base upon clinical outcome among diabetic participant follow cataract surgery .</brief_summary>
	<brief_title>Nepafenac Once Daily Macular Edema - Study 2</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Planned cataract extraction phacoemulsification implantation posterior chamber intraocular lens ; History Type 1 2 diabetes nonproliferative diabetic retinopathy ( NPDR ) ( mild , moderate , severe ) study eye ; Bestcorrected visual acuity ( BCVA ) 73 letter bad study eye expectation improvement surgery ; Understand sign inform consent document ; Other protocoldefined inclusion criterion may apply . Preexisting macular edema study eye ; History study eye retinal detachment , wet agerelated macular degeneration , chronic recurrent inflammatory eye disease , prior procedure ; Planned cataract surgery fellow eye prior Day 90 postoperative study visit study exit ; Planned multiple procedure study eye cataract/intraocular lens ; Use exclusionary medication , include nonsteroidal antiinflammatory drug ( NSAIDs ) steroid , specify protocol . Participation clinical study within 30 day screen visit ; Females childbearing potential breast feeding , positive urine pregnancy test screening , willing undergo urine pregnancy test upon enter exit study , intend become pregnant study , agree use adequate birth control method duration study ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Diabetes Type I</keyword>
	<keyword>Diabetes Type II</keyword>
	<keyword>Non-proliferative diabetic retinopathy</keyword>
	<keyword>Macular edema</keyword>
	<keyword>Cataract</keyword>
</DOC>